Registered Malawi · PMRA

FIBROSAL 50MG/G CREAM

METHYLSALICYLATE BP

PMPB/PL7/44 CREAM

What it does

Methylsalicylate is a topical treatment used to relieve pain and inflammation in muscles and joints.

Commonly used for: muscle pain, joint pain, arthritis, back pain

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
PMPB/PL7/44
Registration date
29/05/2001
Expiry date
30/06/2006
Status
Registered
Active ingredient
METHYLSALICYLATE BP
Dosage form
CREAM
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
-
Applicant / LTR
-
Country of origin
-

Source: Pharmacy and Medicines Regulatory Authority · fetched 2026-04-21 17:37:47 · updated 2026-09-19 04:30:23

Disclaimer: This information is sourced from Pharmacy and Medicines Regulatory Authority (Malawi). Always consult a qualified healthcare professional before using any medication.

About this medicine

Methylsalicylate is a topical treatment used to relieve pain and inflammation in muscles and joints.

What it treats

  • muscle pain
  • joint pain
  • arthritis
  • back pain

How it works

It works by creating a cooling sensation that helps to reduce pain and swelling in the affected area.

Who it's for

It is suitable for adults and children over the age of 12 who are experiencing muscle or joint pain.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: methylsalicylate

BNF-referenced

Methylsalicylate is an organic ester of salicylic acid, commonly used as a topical analgesic for the relief of musculoskeletal pain. It acts primarily as a counter-irritant, helping to alleviate pain through its irritant effects on the skin, which can mask underlying discomfort in muscles and joints.

Indications

  • Musculoskeletal pain
  • Arthritis
  • Tendonitis
  • Sprains and strains
  • Back pain

Dosage

Children: Refer to BNF for Children for appropriate dosing in children.

Adults: Apply to the affected area 3 to 4 times daily as needed. Do not exceed the recommended dose.

Mechanism of action

Counter-irritation is thought to be effective at alleviating musculoskeletal pain as the irritation of the sensory nerve endings alters or offsets pain in the underlying muscle or joints that are served by the same nerves. When applied topically, methyl salicylate penetrates the skin and underlying tissues where it reversibly inhibits cyclooxygenase enzymes, preventing the production of inflammatory mediators such as prostaglandin and thromboxane A2.

Pharmacodynamics

Methyl salicylate relieves musculoskeletal pain in muscles, joints, and tendons by causing irritation and reddening of the skin due to dilated capillaries and increased blood flow. It is pharmacologically similar to aspirin and other NSAIDs, primarily acting as a rubefacient and skin irritant. The counter-irritation effect is believed to produce a soothing sensation of warmth.

Pharmacokinetics

Methylsalicylate is absorbed through the skin, and its effects are localized to the site of application. The ester is metabolized in the liver, where it is hydrolyzed to salicylic acid, which can contribute to its analgesic effects. The elimination half-life is variable and can be influenced by the route of administration and individual patient factors.

Adverse effects

  • Skin irritation
  • Burning sensation
  • Allergic reactions
  • Rash

Precautions

  • Avoid contact with eyes and mucous membranes
  • Do not apply to broken or irritated skin
  • Use with caution in patients with a history of allergic reactions to salicylates
  • Not recommended for use in children without medical advice

Pregnancy

Methylsalicylate should be used during pregnancy only if clearly needed. The potential risks and benefits must be assessed by a healthcare provider.

Breast-feeding

It is not known whether methylsalicylate is excreted in human milk. Caution should be exercised when administering to nursing women.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Formulations

  • Topical ointment
  • Topical cream
  • Topical gel

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: methylsalicylate

PubChem CID 4133

Molecular formula: C8H8O3

Mechanism of action

Counter-irritation is thought to be effective at alleviating musculoskeletal pain as the irritation of the sensory nerve endings is thought to alter or offset pain in the underlying muscle or joints that are served by the same nerves. This is thought to mask the underlying musculoskeletal pain and discomfort. When applied topically, methyl salicylate is thought to penetrate the skin and underlying tissues where it reversibly inhibits cyclooxygenase enzyme and locally and peripherally prevents the production of inflammatory mediators such as prostaglandin and thromboxane A2.

Pharmacodynamics

Methyl salicylate relieve musculoskeletal pain in the muscles, joints, and tendons by causing irritation and reddening of the skin due to dilated capillaries and increased blood flow. It is pharmacologically similar to aspirin and other NSAIDs but as a topical agent it primarily acts as a rubefacient and skin irritant. Counter-irritation is believed to cause a soothing sensation of warmth.

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.